SHARE
COPY LINK

HEALTH

Respiratory infections soar in Spain over Christmas as hospitals struggle

Cases of viral respiratory infections such as flu, Covid and bronchitis have shot up over the past few weeks in Spain, putting an enormous strain on hospitals across the country and causing a severe lack of beds.

Respiratory infections soar in Spain over Christmas as hospitals struggle
Respiratory viruses skyrocket in Spain as hospitals face collapse. Photo: Josep LAGO / AFP

Winter colds and flu are common, but this year Spain has seen a spike in cases of three different viruses – flu, Covid and bronchitis at the same time.

This comes after the festive and New Year period with lots of family gatherings and meetings with friends without much thought for social distancing days of the pandemic.

Rise in cases

According to health services, there are 35 percent more cases of these infections than a year ago, a percentage that is expected to continue rising until the third week of January when the epidemic peak will be reached after more gatherings for Three Kings’ Day on January 5th and 6th.

In a period of seven days, the rates of flu have gone from 532 to 908 cases per 100,000 inhabitants. The cases of Covid have also grown from 12.6 percent to 13.6 percent.

The Health Minister, Monica García has published a message on social media reminding the public of the importance of getting vaccinated and maintaining prevention measures, such as ventilating rooms, washing hands and wearing a mask.

The head of the Emergency Department at the Reina Sofía University Hospital in Murcia, explained that the profile of these patients ranges “from young people with flu pathologies who go to the emergency room because health centres have delayed their appointments and people over 80 years old with pneumonia due to the flu who end up being admitted”.

Lack of hospital beds

According to the first vice president of the Spanish Society of Emergency Medicine (SEMES), Pascual Piñera, 10 of patients with these infections end up admitted to hospital overnight and one of the biggest problems staff are facing is the severe lack of beds, “They have nowhere to put the sick”, he explained.

The situation is the same all over the country. Red Workers union of the La Paz University Hospital in Madrid has reported that there are 105 patients pending admission and beds in the hallways are in double rows, “which cannot be evacuated if the patient worsens or there is a fire”.

Delays in primary health care 

Acute respiratory infections not only put a strain on hospitals and emergency rooms, but also primary care centres, causing delays and long waiting times for appointments. 

The spokesperson for the Federation of Associations for the Defence of Public Health (FADSP), Marciano Sánchez Bayle, explains that it is generating a “major traffic jam” in the healthcare system “where appointments are made for very late dates”.

Sánchez Bayle cites the case of the Community of Madrid, where he knows that appointments requested in December were not given until the end of January “which further clogs an already saturated system”. 

The need for greater vaccination rates 

Besides the festive period, many health professionals believe that the situation could be improved if more people were getting vaccinated, specifically against the flu. 

Flu vaccination in Spain is far below the WHO recommendations, hovering around 50 percent of the population at risk, when the goal is 75 percent. And the percentage is even lower in the case of children under five.

According to the Ministry of Health, the objectives for vaccination against flu and Covid-19 for the 2023-2024 season are to achieve or exceed vaccination coverage of 75 percent in older people and health workers, as well as 60 percent for pregnant women and people with at-risk conditions.

Amós García Rojas from Spain’s Vaccinology Association believes that after a few years without flu during the Covid pandemic, society has relaxed.

The vaccination campaign has not yet ended, so there’s still time to get yours before the end of the season. The campaign began on October 15th and ends on January 31st. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

What cancer-fighting immunotherapy does Spain offer?

Spain currently offers several different immunotherapy treatments for cancer, but recently there have been several developments with two new therapies approved for use in the public health system.

What cancer-fighting immunotherapy does Spain offer?

The Spanish Medicines Agency (Aemps) has recently approved a new CAR-T therapy, which is only the second public immunotherapy in the world for multiple myeloma, the second most common blood cancer behind chronic lymphatic leukaemia. 

This is a type of cancer that forms in certain white blood cells called plasma cells.  

The new CAR-T therapy has been manufactured entirely by Hospital Clínic in Barcelona. According to reports, there is no other hospital in the world that has manufactured a product of this type.  

CAR-Ts are a type of advanced immunotherapy, treating not only blood cancers, but tumours or diseases such as lupus or multiple sclerosis. It works by carrying out a genetic modification of the patient’s blood.  

The Aemps Committee for the Evaluation of Medicines for Human Use has given the green light for Hospital Clínic’s CAR-T ARI-0002 as an advanced therapy medicine in patients with multiple myeloma in a situation of relapse. This was announced this Friday at a press conference by the Barcelona hospital and the Department of Health. 

It now means that oncology departments across Spain will be able to use this type of therapy, without patients having to travel to Barcelona for treatment. 

Spain’s Health Ministry has also authorised the financing of another new immunotherapy treatment, designed to help fight a range of different types of cancers, mainly types of tumours.  

This will replace the current intravenous drip with a subcutaneous injection, reducing treatment time from one hour to seven minutes, without losing its effectiveness.

The injection, called atezolizumab, will be given to patients once every three weeks without need to remain in hospital for observation afterwards, meaning it’s not only easier for them, but it also saves health resources too.

Atezolizumab was authorised by the European Medicines Agency (EMA) last January and will be used treat the same nine conditions as the intravenous drug, mainly tumours of the lung, liver, bladder and breast.

Manual widget for ML (class=”ml-manual-widget-container”)

It will also be used for some of the most aggressive and difficult-to-treat forms of cancer, such as early-stage non-small cell lung cancer or for various forms of metastatic cancer; hepatocellular carcinoma and alveolar soft-part sarcoma, among others. 

Immunotherapy treatments for cancer differ from chemotherapy in that it helps the body identify and attack cancer cells better using its own immune system. This means it can continue to work even when the treatment has ended.  

Chemotherapy on the other hand kills fast growing cells, which can be cancerous as well as non-cancerous.  

Both treatments are still used for different types of cancer and different patients or even in combination with each other. Chemotherapy can work more quickly for example, but immunotherapy can help over a longer period of time and is less invasive and damaging to the body.

According to the recent IMscin002 immunotherapy trail, the subcutaneous injection is preferred by 79 percent of patients, because they find it less invasive, painful and annoying, which results in a higher quality of life.  

Nine out of ten healthcare professionals agreed that the injection is easy to administer and three out of four said it could save time too.

The approval of the new drug in Spain’s public health system is based on data from the phase III IMscin001 trail, in which seven Spanish centres participated, totalling 20 percent of the number of patients recruited for it worldwide. This showed that the injection was found to be just as safe and efficient as the intravenous option.

Spain is a world leader in CAR-T research, an immunotherapy that has already treated more than 1,000 patients in the country and that has proven to be effective against certain types of cancer, such as breast cancer or glioblastoma of the brain, but especially haematological cancers, such as leukaemia or lymphoma.

This means that we can expect an increasing number of immunotherapies for cancer to be available through Spain’s public health system in the coming years.

For the treatment of large B-cell lymphoma, mantle cell lymphoma, multiple myeloma, and acute lymphoblastic leukaemia in adults, the following hospitals in Spain offer immunotherapy:

  • Donostia University Hospital (Basque Country).
  • University Hospital Complex of A Coruña (Galicia)
  • Reina Sofia University Hospital (Andalusia).
  • Regional University Hospital of Malaga (Andalusia).
  • Central University Hospital Complex of Asturias (Asturias).
  • Marquis of Valdecilla University Hospital (Cantabria).
  • Virgen de la Arrixaca University Clinical Hospital (Murcia Region).
  • Morales Meseguer University Clinical Hospital (Murcia Region).
  • Son Espases University Hospital (Balearic Islands).
  • Puerta del Hierro Hospital in Majadahonda (Community of Madrid).
  • Ramon y Cajal University Hospital (Community of Madrid).
  •  Hospital 12 de octubre (Community of Madrid).
  • La Paz University Hospital (Community of Madrid).
  • La Princesa University Hospital (Community of Madrid).
  • Hospital Clínic de Barcelona (Catalonia)
  • Sant Joan de Déu Hospital (Catalonia)

For the treatment of acute lymphoblastic leukaemia in paediatrics, the following hospitals in Spain offer treatment:

  • University Hospital Complex of Santiago de Compostela (Galicia)
  • Reina Sofia University Hospital (Andalusia)
  • Regional University Hospital of Malaga (Andalusia)
  • Virgen de la Arrixaca University Hospital (Murcia Region)
  • Son Espases University Hospital (Balearic Islands)
SHOW COMMENTS